Andrew Mendlowitz PhD, MBiotech, is currently a Scientific Associate at the Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network. He holds appointments as Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto; and Adjunct Professor in the School of Health Policy and Management at York University. Andrew completed his doctoral studies at the University of Toronto in Health Services Research – Health Technology Assessment. He completed a Postdoctoral Fellowship through the Toronto Centre for Liver Disease. He also holds a Master of Biotechnology from University of Toronto. Andrew has been the recipient of awards from the Canadian Institutes for Health Research (CIHR) and the Canadian Network on Hepatitis C (CanHepC). Prior to his doctoral training, Andrew worked in the pharmaceutical industry in health technology assessment, medical education, and enterprise operations.